NCT05097573View on ClinicalTrials.gov

Clinical Evaluation of the Efficacy of Fractional Radiofrequency for the Treatment and Reduction of Stretch Marks

NACompletedINTERVENTIONAL
Enrollment

17

Participants

Timeline

Start Date

May 9, 2019

Primary Completion Date

August 27, 2021

Study Completion Date

October 4, 2021

Conditions
Stretch Mark
Interventions
DEVICE

Venus Viva

The Venus Viva™ fractional RF device has been shown in clinical studies to improve various skin conditions related to aging and alter collagen structures such as wrinkles, stretch marks, rhytids and scars. Beginning with the Baseline visit (Visit 1), subjects will receive a total of 4 treatments approximately 4 weeks apart.

Trial Locations (1)

Unknown

Skinpulse Dermatologie, Geneva

All Listed Sponsors
lead

Venus Concept

INDUSTRY

NCT05097573 - Clinical Evaluation of the Efficacy of Fractional Radiofrequency for the Treatment and Reduction of Stretch Marks | Biotech Hunter | Biotech Hunter